Trial Profile
Outcome and cause of death in sorafenib-treated hepatocellular carcinoma patients with extrahepatic metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 12 Aug 2015 New trial record